Time to end secret data laboratories—starting with the CDC
The American people are waking up to the fact that too many public health leaders have not always been straight with them. Despite housing treasure…
Thought Leader: Marty Makary
Dr. Scott Gottlieb on the impact of Pres. Trump’s policies on Big Pharma and R&D
Former FDA Commissioner Dr. Scott Gottlieb joins ‘Squawk Box’ to discuss the impact of President Trump’s tariff policy and executive order on the pharmaceutical industry, impact on R&D and new drug development, and more.
Dr. Scott Gottlieb, former FDA Commissioner, brings deep insight into the intersection of healthcare policy and pharmaceutical innovation. With extensive experience in public health leadership, he provides expert analysis on the impacts of regulation, tariffs, and industry trends. For speaking inquiries, contact WWSG.
Relevant posts
David Frum: How Harris Roped a Dope
This piece is by WWSG exclusive thought leader, David Frum. Vice President Kamala Harris walked onto the ABC News debate stage with a mission: trigger…
Thought Leader: David Frum
Michael Baker: Ukraine’s Faltering Front, Polish Sabotage Foiled, & Trump vs. Kamala
In this episode of The President’s Daily Brief with Mike Baker: We examine Russia’s ongoing push in eastern Ukraine. While Ukrainian forces continue their offensive…
Thought Leader: Mike Baker
More with this speaker
Dr. Scott Gottlieb on Funding Cuts for Health Research
Thought Leader: Scott Gottlieb
Dr. Scott Gottlieb: FDA Cuts May Stall Drug Access
Thought Leader: Scott Gottlieb